These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30630669)

  • 21. Treat-to-target HbA
    Gagliardino JJ; Elgart J; Forti L; Guaita MS; Chantelot JM
    Diabetes Metab Res Rev; 2019 Sep; 35(6):e3166. PubMed ID: 30963685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. American College of Physicians diabetes guidelines attempt to turn back the clock, conflating good HbA1c with hypoglycemia.
    Bloomgarden Z; Einhorn D; Handelsman Y; Misra A; Zonszein J; Grunberger G; Jellinger PS; Garber AJ
    J Diabetes; 2018 Aug; 10(8):618-620. PubMed ID: 29655268
    [No Abstract]   [Full Text] [Related]  

  • 23. Therapeutic inertia in patients treated with two or more antidiabetics in primary care: Factors predicting intensification of treatment.
    Mata-Cases M; Franch-Nadal J; Real J; Gratacòs M; López-Simarro F; Khunti K; Mauricio D
    Diabetes Obes Metab; 2018 Jan; 20(1):103-112. PubMed ID: 28656746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of preprocedural glycemic control on clinical outcomes of endovascular therapy in diabetic patients with lower extremity artery disease: an analysis from a Korean multicenter retrospective registry cohort.
    Cha JJ; Kim H; Ko YG; Choi D; Lee JH; Yoon CH; Chae IH; Yu CW; Lee SW; Lee SR; Choi SH; Koh YS; Min PK;
    Cardiovasc Diabetol; 2020 Jun; 19(1):97. PubMed ID: 32571352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II).
    Boytsov S; Logunova N; Khomitskaya Y;
    Cardiovasc Diabetol; 2017 Dec; 16(1):158. PubMed ID: 29246151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Diabetic Status and Glycemic Control With Ischemic and Bleeding Outcomes in Patients With Stable Coronary Artery Disease: The 5-Year CORONOR Registry.
    Lemesle G; Meurice T; Tricot O; Lamblin N; Bauters C
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29728374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. All-cause mortality and pharmacological treatment intensity following a high risk screening program for diabetes. A 6.6 year follow-up of the ADDITION study, Denmark.
    Lauritzen T; Sandbaek A; Carlsen AH; Borch-Johnsen K
    Prim Care Diabetes; 2012 Oct; 6(3):193-200. PubMed ID: 22595031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mismatch between ADA and AGS recommendations for glycated hemoglobin targets for older adults.
    Tasci I; Safer U; Naharci I; Sonmez A
    Prim Care Diabetes; 2018 Apr; 12(2):192-194. PubMed ID: 29396204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in the management of type 2 diabetic patients in family medicine practices in the Bursa region.
    Göktaş O; Öz Gül Ö; Ertürk E
    Prim Care Diabetes; 2017 Apr; 11(2):178-183. PubMed ID: 27852516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health care delivery in type 2 diabetes. A survey in an Italian primary care practice.
    Modesti A; Bartaloni R; Bellagamba F; Caglieri R; Cenori K; Ciampalini G; Costagli A; Galloni V; Del Papa C; Modesti L; Dell'Omo G; Pedrinelli R
    Prim Care Diabetes; 2015 Feb; 9(1):9-14. PubMed ID: 24908631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Purified Anthocyanins in Improving Cardiometabolic Risk Factors in Chinese Men and Women with Prediabetes or Early Untreated Diabetes-A Randomized Controlled Trial.
    Yang L; Ling W; Yang Y; Chen Y; Tian Z; Du Z; Chen J; Xie Y; Liu Z; Yang L
    Nutrients; 2017 Oct; 9(10):. PubMed ID: 28994705
    [No Abstract]   [Full Text] [Related]  

  • 32. Optimal Hemoglobin A1c Levels for Screening of Diabetes and Prediabetes in the Japanese Population.
    Shimodaira M; Okaniwa S; Hanyu N; Nakayama T
    J Diabetes Res; 2015; 2015():932057. PubMed ID: 26114121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease - cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort.
    Busch M; Nadal J; Schmid M; Paul K; Titze S; Hübner S; Köttgen A; Schultheiss UT; Baid-Agrawal S; Lorenzen J; Schlieper G; Sommerer C; Krane V; Hilge R; Kielstein JT; Kronenberg F; Wanner C; Eckardt KU; Wolf G;
    BMC Nephrol; 2016 Jun; 17(1):59. PubMed ID: 27286816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variation in HbA1c prescription for patients with diabetes in French general practice: an observational study prior to the implementation of a P4P programme.
    Chauvel N; Le Vaillant M; Pelletier-Fleury N
    Eur J Public Health; 2013 Feb; 23(1):61-6. PubMed ID: 22219502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of prior cerebrovascular disease and glucose status on incident cerebrovascular disease in Japanese.
    Oe M; Fujihara K; Harada-Yamada M; Osawa T; Kitazawa M; Matsubayashi Y; Sato T; Yaguchi Y; Iwanaga M; Seida H; Yamada T; Sone H
    Cardiovasc Diabetol; 2021 Sep; 20(1):174. PubMed ID: 34479567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management and treatment goals in Polish patients with type 2 diabetes of short duration: results of the ARETAEUS2-Grupa study.
    Bała MM; Płaczkiewicz-Jankowska E; Leśniak W; Topór-Mądry R; Michałejko M; Jankowski M; Strzeszyński L; Sieradzki J; Czupryniak L;
    Pol Arch Med Wewn; 2013; 123(11):573-81. PubMed ID: 24241157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haemoglobin A1c even within non-diabetic level is a predictor of cardiovascular disease in a general Japanese population: the Hisayama Study.
    Ikeda F; Doi Y; Ninomiya T; Hirakawa Y; Mukai N; Hata J; Shikata K; Yoshida D; Matsumoto T; Kitazono T; Kiyohara Y
    Cardiovasc Diabetol; 2013 Nov; 12():164. PubMed ID: 24195452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HbA1c and the diagnosis of diabetes and prediabetes in a middle-aged and elderly Han population from northwest China (HbA1c).
    Wu S; Yi F; Zhou C; Zhang M; Zhu Y; Tuniyazi Y; Huang L; Huang X; Wang F; Bi Y; Ning G
    J Diabetes; 2013 Sep; 5(3):282-90. PubMed ID: 23452328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and phenotype of diabetes and prediabetes using fasting glucose vs HbA1c in a Caribbean population.
    Unwin N; Howitt C; Rose AM; Samuels TA; Hennis AJ; Hambleton IR
    J Glob Health; 2017 Dec; 7(2):020407. PubMed ID: 28959440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of introducing HbA1c into the diagnostic criteria on prevalence and cardiovascular risk profiles of individuals with newly diagnosed diabetes in Japan: the Toranomon Hospital Health Management Center Study 2 (TOPICS 2).
    Heianza Y; Hara S; Arase Y; Saito K; Tsuji H; Kodama S; Hsieh SD; Mori Y; Okubo M; Yamada N; Kosaka K; Sone H
    Diabetes Res Clin Pract; 2012 Feb; 95(2):283-90. PubMed ID: 22104263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.